Bausch Health Companies (BHC) Common Equity (2009 - 2026)

Bausch Health Companies has disclosed Common Equity across 18 years of filings, most recently posting -$1.1 billion for Q1 2026.

• Common Equity for Q1 2026 came in at -$1.1 billion, down 350.83% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.1 billion (down 350.83% YoY), and the FY2025 annual result was -$554.0 million, up 56.68% from the prior year.
• Common Equity came in at -$1.1 billion for Q1 2026 at Bausch Health Companies, down from -$554.0 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $433.0 million in Q3 2022 to a low of -$1.3 billion in Q4 2024.
• The 5-year median for Common Equity is -$141.0 million (2022), against an average of -$140.6 million.
• Across the five-year window, Common Equity surged 864.71% in 2022 and slumped 1459.76% in 2024, its largest moves.
• Bausch Health Companies' Common Equity stood at $260.0 million in 2022, then plunged by 131.54% to -$82.0 million in 2023, then plunged by 1459.76% to -$1.3 billion in 2024, then soared by 56.68% to -$554.0 million in 2025, then sank by 95.31% to -$1.1 billion in 2026.
• The last three Common Equity figures came in at -$1.1 billion (Q1 2026), -$554.0 million (Q4 2025), and $356.0 million (Q3 2025), per Business Quant data.